Phase 1/2 Trial of Avelumab Combined with Utomilumab (4-1BB Agonist), PF-04518600 (OX40 Agonist), or Radiotherapy in Patients with Advanced Gynecologic Malignancies
CANCER(2024)
关键词
cervical cancer,endometrial cancer,immune checkpoint blockade,immunotherapy,ovarian cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要